Stock screener
All disclosures →
EDGAR →
ARQT
Conviction 77HealthcareScan · Mon, Aug 10, 2026ARQT$25.90+2.41%
ResistanceSupportVol 14Insider sellCongress buyCongress sell3
2
2
Vol MA14 1.95M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price25.90
Change+2.41%
Gap-1.07%
Rel volume4.68×
Avg volume1.76M
Avg $ vol47.38M
SMA 2027.24
SMA 5025.96
SMA 20025.46
Price vs 50-0.22%
Price vs 200+1.72%
MA stackmixed
50/200 crossgolden · 6d
Supertrenddown · 29.28
RSI (14)45
MACD hist-0.34
MACD cross—
Stoch %K / %D23 / 15
ADX (14)24
+DI / −DI26 / 22
RSI divergence—
MACD divergence—
ATR %+4.86%
ADR %4.32%
52w high31.20
52w low14.19
From 52w high-16.99%
Above 52w low+82.52%
New 52w highNo
SqueezeOff
Bollinger width13.19%
%B0.13
Donchian pos23.39%
Donchian high29.24
Donchian low24.88
AVWAP (52w high)25.33
vs AVWAP high+2.25%
AVWAP (52w low)23.91
vs AVWAP low+8.34%
OBV trendFlat
Chaikin MF (20)0.09
Today vs 20d4.68×
Avg vol (14d)1.95M
Avg vol (20d)1.76M
Avg $ vol (20d)47.38M
Market cap3.26B
RS 3m (vs SPY)+16.71%
RS 6m (vs SPY)-17.11%
RS line new highNo
Trend template5/8
Technical rank32.8
1 week-0.15%
1 month-6.63%
3 months+22.34%
6 months-5.20%
1 year+83.43%
YTD-10.69%
P/E-201.69
P/B14.76
P/S8.66
P/FCF-515.83
EPS-0.1300
Div yield—
ROE-7.32%
ROA-3.30%
Debt/Eq0.49
Current2.92
EV/EBITDA—
Gross margin—
Net margin-4.29%
Rev growth91.34%
EPS growth88.47%
Price target36.57
Target upside41.20%
Analyst ratingBuy
Institutional111.80%
Ent. value3.33B
Revenue129.86M
Net income15.01M
Gross profit—
Free cash flow-6.31M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out125.08M
Employees354
ListedFri, Jan 31, 2020
Free float109.34M
Float %89.3%
Short interest13.56M
Days to cover9.3d
Short volume65.8%
Squeeze score82 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.11 vs $0.09
Last surprise+22.2% beat
Setup gradeA
Conviction77 / 100
Pattern quality—
Tech rank32.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance29.54
Support25.44
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ARQT · 1 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Gilbert Cisneros house · CA · traded 2026-05-29 | Buy | $1K–$15K | 2026-05-29 | 2026-06-05 |
Insider activity
SEC Form 4 transactions in ARQT · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Burnett Patrick See Remarks · Common Stock · 2026-08-03 | Sell | 955 | $25K | 2026-08-03 | 2026-08-05 |
Watanabe Todd See Remarks · Common Stock · 2026-08-03 | Sell | 4.38K | $114K | 2026-08-03 | 2026-08-05 |
Matsuda Masaru See Remarks · Common Stock · 2026-08-03 | Sell | 1.23K | $32K | 2026-08-03 | 2026-08-05 |
Welgus Howard G. Director · Common Stock · 2026-07-15 | Exercise | 1.02K | $8K | 2026-07-15 | 2026-07-17 |
Welgus Howard G. Director · Common Stock · 2026-07-15 | Exercise | 2.25K | $19K | 2026-07-15 | 2026-07-17 |
Welgus Howard G. Director · Common Stock · 2026-07-15 | Sell | 4.73K | $127K | 2026-07-15 | 2026-07-17 |
Peetz Christopher Director · Stock Option (right to buy) · 2026-07-15 | Grant | 13.01K | — | 2026-07-15 | 2026-07-17 |
Welgus Howard G. Director · Stock Option (right to buy) · 2026-07-15 | Exercise | 822 | — | 2026-07-15 | 2026-07-17 |
Welgus Howard G. Director · Stock Option (right to buy) · 2026-07-15 | Exercise | 1.02K | — | 2026-07-15 | 2026-07-17 |
Welgus Howard G. Director · Stock Option (right to buy) · 2026-07-15 | Exercise | 2.25K | — | 2026-07-15 | 2026-07-17 |
SEC filings
EDGAR filings in ARQT · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.